Merck & Co., Inc.

MRK XNYS PHARMACEUTICAL PREPARATIONS

Market Cap

290B

Short interest (May 15)

1.2%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.40%

↑ 24.7%

Available Shares

10M

↓ 0.0%

Price Chart

Company Overview

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Company Info

Exchange: NYSE
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0000310158
Asset Type: CS

Market Data

Market Cap: $285,635,193,594
Employees: 75,000
Status: Active

Short Interest

Current Borrow Fee 0.40%
Range: 0.40% - 0.41%
Available Shares 10M
Range: 10M - 10M

Recent Changes

Fee Change: ↓ 0.7%
Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime